ECG Signal Quality Characterization for QT Interval Accuracy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ECG devices and methods for measuring QT/QTc intervals are not accurate or precise enough, leading to unnecessary patient exclusions and recruitment inefficiencies in clinical trials, due to variability in cardiac beat quality and automated measurements diverging from centralized lab results.
Innovation Solution
Characterizing ECG signal quality using a dispersion coefficient and deviation from average ECG parameters to rank cardiac beats, allowing for the selection of high-quality sequences for QT evaluation, thereby improving the accuracy of QT, PR, and QRS interval measurements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If automated ECG machines are used to measure QT/QTc intervals at clinical trial sites, then measurement speed and efficiency are improved, but measurement precision and accuracy deteriorate due to divergence from centralized lab results
Solution Approach 1:
The patent segments the ECG analysis process into two parts: automated acquisition at the site and centralized re-analysis at the core laboratory. The automated machine performs initial screening and data collection, while the centralized laboratory performs detailed, accurate measurement of QT/QTc intervals using the recorded ECG data, thereby combining speed with precision.
Solution Approach 2:
The patent introduces an intermediary process where ECG recordings are transmitted from the automated site-based machine to a centralized core laboratory. This intermediary step allows the benefits of automated acquisition to be preserved while enabling expert, standardized analysis at the laboratory, resolving the accuracy-precision tradeoff.
2Productivity
If automated ECG measurements are used for subject inclusion/exclusion decisions, then recruitment process is accelerated, but reliability deteriorates leading to unnecessary patient exclusions
Solution Approach 1:
The patent implements preliminary automated screening at the clinical trial site to quickly identify potential subjects who meet inclusion/exclusion criteria. This preliminary action accelerates the recruitment process by filtering candidates before they undergo the full, more reliable centralized ECG analysis, thus speeding up recruitment without sacrificing final selection accuracy.
Solution Approach 2:
The patent establishes a feedback mechanism where automated ECG measurements are reviewed and validated by centralized core laboratory analysis. This feedback loop ensures that automated screening decisions are verified against more reliable centralized measurements, preventing unnecessary exclusions while maintaining recruitment efficiency.
3Ease of operation
If poor quality cardiac beats are selected for QT/QTc measurement, then measurement process is simplified, but measurement precision deteriorates
Solution Approach 1:
The patent implements an automated quality assessment system that self-evaluates cardiac beats based on predefined quality criteria. The system automatically identifies and selects high-quality beats for QT/QTc measurement without requiring manual review, thereby maintaining measurement simplicity while ensuring precision through objective quality filtering.
Solution Approach 2:
The patent changes the selection parameter from simple automated measurement to quality-gated selection. By introducing quality parameters (such as signal-to-noise ratio, morphological consistency, and artifact absence) as selection criteria, the system ensures that only high-quality beats are used for QT/QTc measurement, thereby maintaining precision while keeping the process automated and simple.
Data Source
AI summary
Described here are methods, devices and systems for characterizing a physiological signal such as an electrocardiogram (ECG) signal. Generally, the method includes receiving the ECG signal generated by an ECG device coupled to a patient. ECG signal quality for a plurality of consecutive beats may be determined based on a dispersion coefficient and a deviation from an average of each of a plurality of ECG parameters. Indexing information may be generated for set of sequences from the plurality of consecutive cardiac beats. Each of the sequences may comprise a first predetermined number of consecutive cardiac beats. The set of the sequences may be ordered based upon the ECG signal quality.